English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52741569    線上人數 :  646
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu c l"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 231-240 / 696 (共70頁)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-04-29T05:09:15Z Management of severe community-acquired septic meningitis in adults: From emergency department to intensive care unit Hsu C.-L.; Chang C.-H.; Wong K.-N.; KUAN-YU CHEN; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:13Z Hemothorax in a Medical Intensive Care Unit: Incidence, Comorbidity and Prognostic Factors Chen C.-Y.; Hsu C.-L.; Chang C.-H.; KUAN-YU CHEN; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:10Z Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors Hsu C.-L.; KUAN-YU CHEN; Shih J.-Y.; Ho C.-C.; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:04Z Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis Hsu C.-L.; Chen J.-H.; KUAN-YU CHEN; Shih J.-Y.; Yang J.C.H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:02Z Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission Chien Y.-F.; Chen C.-Y.; Hsu C.-L.; KUAN-YU CHEN; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:55Z Histologic Transformation in a Patient with Lung Cancer Treated with Chemotherapy and Pembrolizumab Hsu C.-L.; KUAN-YU CHEN; Kuo S.-W.; Chang Y.-L.
臺大學術典藏 2021-04-29T05:08:54Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; KUAN-YU CHEN; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:51Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Ho C.-C.;Hsu C.-L.;Yang C.-Y.;Kuan-Yu Chen;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; KUAN-YU CHEN; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:50Z Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Kuan-Yu Chen;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; KUAN-YU CHEN; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:48Z Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Kuan-Yu Chen;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; KUAN-YU CHEN; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.

顯示項目 231-240 / 696 (共70頁)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每頁顯示[10|25|50]項目